Fertility Drugs and Surgery Market Growth Overview 2019 To 2023: Clinical Review, Industry Size, Demand Analysis, Technology Enhancements and Rising Trends

Fertility Drugs and Surgery Market Growth Overview 2019 To 2023: Clinical Review, Industry Size, Demand Analysis, Technology Enhancements and Rising Trends

Fertility Drugs and Surgery Market
Global Fertility Drug and Surgery Market Treatment Analysis and Trends by Underlying Cause (Male and Female), Drugs (Clomiphene Citrate, Letrozole), Procedures (Hysteroscopy, Laparoscopy, Robotic Laparoscopy), and End User (Fertility Clinics) — Forecast till 2023

The global fertility drug and surgery market is expected to exhibit a strong 9.8% CAGR over the forecast period from 2018 to 2023, according to the latest research report from Market Research Future (MRFR).

Fertility drugs and surgery are used when a couple can’t conceive through natural means. The problems with fertility are diverse and can occur with both men and women, making the field difficult to navigate and important. Fertility healthcare has been one of the most prominent and laudable offshoots of the healthcare sector over the last few decades, as it has allowed several couples who wouldn’t have otherwise conceived to conceive and have children. Modern healthcare has allowed for the development of effective treatments for both male and female infertility, leading to the fertility drug and surgery market taking on an important position.

Avail FREE Sample at: https://www.marketresearchfuture.com/sample_request/7588

Competitive Analysis:

Leading players in the global fertility drug and surgery market include

Emd Serono Inc.

Procter & Gamble Pharmaceuticals

Pfizer Inc.

Personal Products Company

Janssen Pharmaceuticals Inc.

Organon Inc.

Noven Pharmaceutical

Merck & Co.

Ferring Pharmaceuticals Inc.

Baxter Healthcare Corporation

and Eli Lilly.

In October 2019, the Sheffield Teaching Hospitals NHS Foundation Trust in Yorkshire received a GBP 1.78 million grant to conduct a trial examining the way women suffering from side effects of fertility treatments are treated.

Market Segmentation:

The global fertility drug and surgery market is segmented on the basis of underlying cause, drug, procedures, end user, and region.

On the basis of the underlying cause, the global fertility drug and surgery market is segmented into male and female.

By drug, the global fertility drug and surgery market is categorized into clomiphene citrate, letrozole, Serophene, hormone treatment, gonadotrophins, aromatase inhibitors, estrogen receptor modulators, dopamine agonists, metformin hydrochloride, and others.

On the basis of procedures, the global fertility drug and surgery market is segmented into hysteroscopy, laparoscopy and robotic laparoscopy, laparotomy/open surgery, egg retrieval, varicocelectomy, vasectomy reversal (vasovasostomy or vasoepididymostomy), and sperm retrieval (epididymal aspiration).

By end user, the global fertility drug and surgery market is categorized into fertility clinics, hospitals, clinical research institutes, and others.

LIST OF TABLES

TABLE 1 GLOBAL FERTILITY DRUG AND SURGERY MARKET SYNOPSIS, 2018–2023

TABLE 2 GLOBAL FERTILITY DRUG AND SURGERY MARKET ESTIMATES AND FORECAST, 2018–2023 (USD MILLION)

TABLE 3 GLOBAL FERTILITY DRUG AND SURGERY MARKET, BY UNDERLYING CAUSE, 2018–2023 (USD MILLION)

TABLE 4 GLOBAL FERTILITY DRUG AND SURGERY MARKET, BY DRUGS, 2018–2023 (USD MILLION)

TABLE 5 GLOBAL FERTILITY DRUG AND SURGERY MARKET, BY PROCEDURES, 2018–2023 (USD MILLION)

TABLE 6 GLOBAL FERTILITY DRUG AND SURGERY MARKET, BY END USERS, 2018–2023 (USD MILLION)

TABLE 7 GLOBAL FERTILITY DRUG AND SURGERY MARKET, BY REGION, 2018–2023(USD MILLION)

…Continued.

Browse Complete Premium Research Report at: https://www.marketresearchfuture.com/reports/fertility-drug-surgery-market-7588

Regional Analysis:

The Americas are the dominant regional market in the global fertility drug and surgery market, followed by Europe. The growing prevalence of sedentary lifestyles and obesity in the Americas, particularly in the U.S., is likely to be a major driver for the fertility drug and surgery market in the Americas over the forecast period. Asia Pacific is also likely to be a strong segment over the forecast period due to the growing awareness about women’s health and fertility treatments in the region.

The global fertility drug and surgery market is profiled in great detail in the report, which reveals the historical growth trajectory of the market in detail in order to make sense of the market’s current position and likely future growth prospects. The major factors having a lasting impact on the fertility drug and surgery market are assessed in the report in order to present a comprehensive overview of the market. Leading economic indicators are assessed in order to present a comprehensive overview of the background of the global fertility drug and surgery market. The key players operating in the global fertility drug and surgery market are also assessed in the report in order to provide readers with a complete overview of the market’s competitive landscape.

Contact:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com

Media Contact
Company Name: Market Research Future
Contact Person: Abhishek Sawant
Email: Send Email
Phone: +1 646 845 9312
Address:Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar
City: Pune
State: Maharashtra
Country: India
Website: https://www.marketresearchfuture.com/reports/fertility-drug-surgery-market-7588